Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
beneficiary, collaboration, dosage, enacted, Enhanze, expediting, failed, foreseeable, forseeable, goal, HHD, immunodeficiency, innovation, insignificant, issuance, kitting, legislation, lyophilized, manner, met, milestone, opportunity, pandemic, Paraxel, profitability, reinvested, relationship, remitted, route, seasonal, spurred, staffing, successful, Teva, tubing, underway, usage, valuation
Removed:
GAAP, mentioned, resumed, SEC
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 15 Letter Re Unaudited Interim Financial Information
- 31.1 Certification of Chief Executive Officer Pursuant to Rule 13A-14(A)/15D-14(A)
- 31.2 Certification of Chief Financial Officer Pursuant to Rule 13A-14(A)/15D-14(A)
- 32.1 Certification of Chief Executive Officer Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of Chief Financial Officer Pursuant to 18 U.s.c. Section 1350
Related press release
BAX similar filings
Filing view
External links